Biotricity, Inc. (OTCMKTS:BTCY – Get Free Report)’s stock price dropped 15.8% on Wednesday . The company traded as low as $0.32 and last traded at $0.32. Approximately 34,342 shares were traded during trading, a decline of 16% from the average daily volume of 40,807 shares. The stock had previously closed at $0.38.
Biotricity Stock Down 15.8 %
The firm’s 50 day moving average is $0.47 and its two-hundred day moving average is $0.37. The stock has a market cap of $7.97 million, a price-to-earnings ratio of -0.19 and a beta of 1.32.
Biotricity (OTCMKTS:BTCY – Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. The company had revenue of $3.62 million for the quarter, compared to analyst estimates of $3.30 million. On average, analysts anticipate that Biotricity, Inc. will post -1.43 EPS for the current fiscal year.
Biotricity Company Profile
Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.
See Also
- Five stocks we like better than Biotricity
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.
